- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Patent holdings for IPC class A61K 47/60
Total number of patents in this class: 4106
10-year publication summary
|
249
|
392
|
475
|
459
|
495
|
476
|
453
|
427
|
349
|
182
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Nektar Therapeutics | 402 |
85 |
| Hanmi Pharm. Co., Ltd. | 601 |
71 |
| The Regents of the University of California | 20745 |
66 |
| Ascendis Pharma A/S | 195 |
48 |
| Bristol-myers Squibb Company | 4742 |
47 |
| The Johns Hopkins University | 5882 |
44 |
| Ascendis Pharma Growth Disorders A/S | 61 |
43 |
| Massachusetts Institute of Technology | 10251 |
39 |
| Board of Regents, The University of Texas System | 6107 |
34 |
| Ascendis Pharma Bone Diseases A/S | 56 |
30 |
| Amgen Inc. | 4427 |
26 |
| Apellis Pharmaceuticals, Inc. | 136 |
26 |
| Northwestern University | 3543 |
25 |
| NOK Corporation | 2299 |
24 |
| ProLynx LLC | 60 |
24 |
| Janssen Pharmaceutica N.V. | 3168 |
23 |
| Quiapeg Pharmaceuticals AB | 38 |
22 |
| Synthorx, Inc. | 48 |
22 |
| The Board of Trustees of the Leland Stanford Junior University | 6653 |
21 |
| The University of Tokyo | 4361 |
21 |
| Other owners | 3365 |